Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00191841
NCT00191841
Completed
Phase 2

Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy in Operable Non Small Cell Lung Cancer

Eli Lilly and Company1 site in 1 country50 target enrollmentDecember 2002
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCarcinoma, Non-Small-Cell Lung
DrugsgemcitabineCisplatin

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Carcinoma, Non-Small-Cell Lung
Sponsor
Eli Lilly and Company
Enrollment
50
Locations
1
Primary Endpoint
Antitumor activity
Status
Completed
Last Updated
19 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

To evaluate the clinical response rate of neoadjuvant chemotherapy with gemcitabine and cisplatin in patients with operable NSCLC

Registry
clinicaltrials.gov
Start Date
December 2002
End Date
February 2006
Last Updated
19 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •histologic or cytologic diagnosis of operable non-small cell lung cancer (IB-IIIA)
  • •no prior chemotherapy
  • •WHO criteria for disease status assessment

Exclusion Criteria

  • •Concurrent administration of any other tumor therapy
  • •pregnant or breast feeding
  • •serious concomitant disorders

Outcomes

Primary Outcomes

Antitumor activity

Secondary Outcomes

  • Duration of response, time to progressive disease, time to treatment failure

Study Sites (1)

Loading locations...

Similar Trials

Active, not recruiting
Phase 1
Prophylactic combined chemotherapy for patients with cholangiocarcinoma after curative intent of carcinoma resection and muscle invasive gallbladder carcinoma.Cholangiocarcinoma and gallbladder carcinomaMedDRA version: 20.0Level: LLTClassification code 10017620Term: Gallbladder carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10008593Term: CholangiocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2012-005078-70-ATniversity Medical Center Hamburg-Eppendorf440
Active, not recruiting
Phase 1
Prophylactic combined chemotherapy for patients with cholangiocarcinoma after curative intent of carcinoma resection and muscle invasive gallbladder carcinoma.Cholangiocarcinoma and gallbladder carcinomaMedDRA version: 20.0Level: LLTClassification code 10017620Term: Gallbladder carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10008593Term: CholangiocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2012-005078-70-ITIVERSITäTKLINIKUM HAMBURG-EPPENDORF781
Active, not recruiting
Phase 1
Prophylactic combined chemotherapy for patients with cholangiocarcinoma after curative intent of carcinoma resection and muscle invasive gallbladder carcinoma.Cholangiocarcinoma and gallbladder carcinomaMedDRA version: 20.0 Level: LLT Classification code 10017620 Term: Gallbladder carcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10008593 Term: Cholangiocarcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2012-005078-70-DKniversity Medical Center Hamburg-Eppendorf60
Recruiting
Phase 3
Adjuvant chemotherapy with gemcitabine and cisplatin compared to standard of care after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial)Biliary tract cancerCholangio/gallblader carcinoma10019815
NL-OMON53034Amsterdam UMC172
Active, not recruiting
Phase 1
Prophylactic combined chemotherapy for patients with cholangiocarcinoma after curative intent of carcinoma resection and muscle invasive gallbladder carcinoma.Cholangiocarcinoma and gallbladder carcinomaMedDRA version: 20.0Level: LLTClassification code 10017620Term: Gallbladder carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10008593Term: CholangiocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2012-005078-70-DEniversity Medical Center Hamburg-Eppendorf781